Integrated clinical-radiomic model for predicting treatment response of concurrent chemo-radiotherapy and radiotherapy alone in controversial subgroup of AJCC/UICC ninth edition stage I nasopharyngeal cancer

Ka Yan Ng, Xinyue Chen, Mohan Huang, Luoyi Kong, Steven Kwoon-Ting Cheung, Lawrence Wing Chi Chan

2025, 37(2): 119-137. doi: 10.21147/j.issn.1000-9604.2025.02.01

Genomic spectra of lymphovascular invasion in breast cancer

Chuhan Shen, Caijin Lin, Feilin Qu, Chao Chen, Zhiming Shao, Yizhou Jiang, Xin Hu, Genhong Di

2025, 37(2): 138-153. doi: 10.21147/j.issn.1000-9604.2025.02.02

Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesions

Yanna Chi, Hongrui Tian, Chao Shi, Zhen Liu, Xue Li, Miao Zhang, Jun Liu, Xianmei Chen, Wenlei Yang, Yaqi Pan, Huanyu Chen, Mengfei Liu, Shengjuan Hu, Zhonghu He, Yang Ke

2025, 37(2): 154-164. doi: 10.21147/j.issn.1000-9604.2025.02.03

Pathogenic germline variants in mismatch repair genes in patients with microsatellite instability-high gastric cancer

Jong Hyuk Yun, Geum Jong Song, In Cho, Sangchul Yun, Myoung Won Son, Sang Hyun Kim, Moon-Soo Lee, Yoon Young Choi

2025, 37(2): 165-173. doi: 10.21147/j.issn.1000-9604.2025.02.04

Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter study

Qing Zhong, Yuqin Sun, Mingqiao Lian, Zengbin Wang, Baolong Li, Junhua Yu, Yubin Ma, Shichao Wu, Yonghong Wang, Ju Wu, Jiyun Zhu, Wen Ye, Zhiquan Zhang, Caiming Weng, Dong Wu, Qiuxian Chen, Qiyue Chen, Ping Li, Chaohui Zheng, Lisheng Cai, Changming Huang

2025, 37(2): 174-186. doi: 10.21147/j.issn.1000-9604.2025.02.05

Temporal trends, disease burden and attributable risk factors of stomach and colorectal cancers among 31 countries and territories in Western Pacific region, 2000−2021

Liangyu Kang, Wenxin Yan, Wenzhan Jing, Jinyu He, Ning Zhang, Min Liu, Wannian Liang

2025, 37(2): 187-199. doi: 10.21147/j.issn.1000-9604.2025.02.06

Impact of robotic surgery proportion among minimally invasive gastrectomy on surgical complications

Jeong Ho Song, Yeojin Boo, Sang-Yong Son, Hoon Hur, Sang-Uk Han, and Information Committee of the Korean Gastric Cancer Association

2025, 37(2): 200-211. doi: 10.21147/j.issn.1000-9604.2025.02.07

Targeted activation of junctional adhesion molecule-like protein+ CD8+ T cells enhances immunotherapy in hepatocellular carcinoma

Huan Chen, Zhaofeng Xiao, Zhengyang Lu, Nan Xu, Qiang Wei, Xiao Xu

2025, 37(2): 212-226. doi: 10.21147/j.issn.1000-9604.2025.02.08

Reprogramming of fatty acid metabolism in thyroid cancer: Potential targets and mechanisms

Pengbin Ping, Yuhong Ma, Xiaoying Xu, Juan Li

2025, 37(2): 227-249. doi: 10.21147/j.issn.1000-9604.2025.02.09

Immune cell-derived exosomal non-coding RNAs in tumor microenvironment: Biological functions and potential clinical applications

Chenguang Liu, Yawen Luo, Huan Zhou, Meixi Lin, Dan Zang, Jun Chen

2025, 37(2): 250-267. doi: 10.21147/j.issn.1000-9604.2025.02.10

Context-dependent roles of 5-HT and its receptors in tumor growth and wound healing: Mechanisms and therapeutic implications

Qingya Zeng, Jiaojiao Zhu, Zongyun He, Hong Qin, Wenhu Zhou, Fangqi Hua, Jin Yang

2025, 37(2): 268-288. doi: 10.21147/j.issn.1000-9604.2025.02.11

Different strategies for cancer treatment: Targeting cancer cells or their neighbors?

Hengrui Liu, James P. Dilger

2025, 37(2): 289-292. doi: 10.21147/j.issn.1000-9604.2025.02.12

Optimizing management of sentinel lymph node limited residual tumor after neoadjuvant therapy for breast cancer: Balancing of act

Jing Sun, Zhiqiang Shi, Zhao Bi, Pengfei Qiu

2025, 37(2): 293-295. doi: 10.21147/j.issn.1000-9604.2025.02.13

Corrigendum to Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial

2025, 37(2): 296-296. doi: 10.21147/j.issn.1000-9604.2025.02.14